Logo-bi
Editorial
Samaneh Alaei ORCID, Hossein Omidian* ORCID
BioImpacts. 2022;12(3): 179-181. doi: 10.34172/bi.2022.24093
PDFPDF
XMLXML
Cited By:
Graphical Abstract
Hossein Omidian is a professor of pharmaceutical sciences at Nova Southeastern University (NSU). His specific research interests are abuse deterrent formulations to combat opioid abuse, gastro-retentive oral delivery to enhance bioavailability of drugs with narrow absorption window, oral-retentive drug carriers to enhance drug bioavailability in oral cavity, and reduce alcohol absorption into the systemic circulation to combat alcohol overdose and toxicity.
Original Research
Solmaz Zakhireh ORCID, Jaleh Barar* ORCID, Younes Beygi-Khosrowshahi, Abolfazl Barzegari, Yadollah Omidi, Khosro Adibkia* ORCID
BioImpacts. 2022;12(3): 183-193. doi: 10.34172/bi.2021.24
PDFPDF
XMLXML
Cited By:
Graphical Abstract
The pollen grain of Pistacia vera L. is proposed as a scaffolding building block with the encapsulation capability of bioactive compounds. A modified simple method was developed to create nonallergic hollow pollen grains (HPGs).
PDFPDF
XMLXML
Cited By:
Graphical Abstract
Chitosan nanoparticle antimiRNA-324-5p could inhibit ovarian cancer proliferation by reduce endogenous miRNA-324-5p to lead restoration of MEN1 and generates repression of GLI1 expression.
Original Research
Shirin Movaghar Asareh ORCID, Tahereh Savei ORCID, Sareh Arjmand* ORCID, Seyed Omid Ranaei Siadat* ORCID, Fataneh Fatemi, Mehrab Pourmadadi, Javad Shabani Shayeh
BioImpacts. 2022;12(3): 203-210. doi: 10.34172/bi.2021.23219
Graphical Abstract
Recombinant heavy and light chains of anti-VEGF-A monoclonal Ab Fab fragment were produced in Pichia pastoris. Reconstruction of Fab fragments was verified by anti-Fab Ab and a split system. An electrochemical setup was used to test the interaction of the reconstructed Fab fragment with VEGF-A.
Original Research
Qiang Yang ORCID, Lei Li ORCID, Zhaohui Liu* ORCID, Chunlei Li ORCID, Lili Yu ORCID, Yulin Chang ORCID
BioImpacts. 2022;12(3): 211-218. doi: 10.34172/bi.2021.23401
PDFPDF
XMLXML
Cited By:
Graphical Abstract
The protective effects of PHC were absent in Nrf2-/- mice. PHC ameliorated RIR-induced lung injury by activating Nrf2 pathway.
Original Research
Forough Shams ORCID, Hamideh Moravvej ORCID, Simzar Hosseinzadeh, Bahram Kazemi, Masoumrh Rajabibazl, Azam Rahimpour* ORCID
BioImpacts. 2022;12(3): 219-231. doi: 10.34172/bi.2021.43
PDFPDF
XMLXML
Cited By:
Graphical Abstract
The present results highlight the potential of reporter gene targeting for the in vitro analysis of biological processes such as migration.
Original Research
Azam Bozorgi ORCID, Masoud Mozafari ORCID, Mozafar Khazaei ORCID, Mansooreh Soleimani* ORCID, Zahra Jamalpoor* ORCID
BioImpacts. 2022;12(3): 233-246. doi: 10.34172/bi.2021.23451
Graphical Abstract
An overview of the fabrication process of pure and Copper (Cu)-substitutednano-hydroxyapatite/chitosan/gelatin (nHA/Cs/Gel) scaffolds followed by the characterization of physical, chemical, and biological properties as proper candidates to bone tissue engineering scaffolds.
Original Research
Marjan Bahraminasab* ORCID, Samaneh Arab, Somaye Ghaffari
BioImpacts. 2022;12(3): 247-259. doi: 10.34172/bi.2021.2330
PDFPDF
XMLXML
Cited By:
Graphical Abstract
Our in-vitro findings demonstrated that the 75Ti, 50Ti, and 25Ti composites havehigh potential to be used as load-bearing orthopedic materials.
Review
Leila Rostamizadeh ORCID, Ommoleila Molavi* ORCID, Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond Lai
BioImpacts. 2022;12(3): 261-290. doi: 10.34172/bi.2022.23896
PDFPDF
XMLXML
Cited By:
Graphical Abstract
In this paper, we will review the application of the four most widely studied TLR agonists including agonists of TLR3, 4, 7, and 9 in cancer immunotherapy.
Perspective
Sajad Khiali ORCID, Afra Rezagholizadeh ORCID, Taher Entezari-Maleki* ORCID
BioImpacts. 2022;12(3): 291-292. doi: 10.34172/bi.2022.23266
PDFPDF
XMLXML
Cited By:
Graphical Abstract
In the present perspective piece, three possible mechanisms of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an oncogenic virus in the lung have been discussed.
Letter to the Editor
Robert C. Speth* ORCID
BioImpacts. 2022;12(3): 293-294. doi: 10.34172/bi.2022.24124
PDFPDF
XMLXML
Cited By:

BioImpacts, as a peer-reviewed international journal, publishes all types of papers on bench-to-bedside translational aspects of pharmaceutical and biomedical sciences. As a "Publish Free" and "Access Free" journal, BioImpacts follows a constructive peer-review process with free editing service to benefit the scientific community worldwide.